Well, what a start to the year! Several things are coming to America. A new Democrat administration keen to sprint out of the blocks, outsized fiscal easing, and wider breakevens (already at well above pre-pandemic levels) are already here. From now, should no mutation hitches stymie reopening plans, outsized job gains, inflation base effects, consumer spending and growth should follow. Then, contingent on the job gains, we should expect the first Fed comments on tapering, probably in May. While value has already begun to build in US Treasuries, with 5y5y forwards already above the Fed’s median longer-run dot, the coast may not be clear – particularly for real yields – until the market has fully priced in tapering.
Beyond the USD 13 trillion US Treasury market, the USD 34 trillion global government complex remains a source of active differentiation – and therefore alpha (both long and short) – within the USD 66 trillion global aggregate universe opportunity set. Correlations, too, are as dynamic as ever, with Bunds and JGBs seeing less than a third and an eighth of the volatility of Treasuries over the year to date. And Italy, China and even the 2yr US Treasury have delivered positive returns for material periods, offering comparative respite. Even in Q1 2021, amid sharply rising yields, you needed to have picked your shorts carefully, by geography and maturity.
Beware the base effects
For Q2 portfolio strategy, we expect to rotate shorts from the US to Bunds in due course, anticipating that the EU’s vaccination programs will eventually get in order and that the ECB will shake off its current timidity over the mighty heights of -0.25% Bund yields. Gilts should continue to bear steepen, albeit to a lesser extent than the US, given greater proposed fiscal restraint. The JGB long end should steepen, too. We think an opportunity on the overweight side will emerge in China as extraordinary economic stimulus from 2020 rolls over first in that market, given that China’s economic hit predated that of the west. Markets are focused on base effects of growth and inflation, but don’t forget the base effects of policy and credit creation.
In credit, investment grade (IG) spreads offer little value in our view – with year-to-date returns in credit heavily dominated by duration rather than the option-adjusted spread (OAS) component. The only difference in investment proposition is that credit carries a bit better than rates, at the cost of considerable latent illiquidity risk. But whereas the underweight in duration is cyclical, we view our underweight in credit as tactical. We expect a much narrower range in IG in 2021 than last year’s drama (see: “Just another range trade”).
High yield may offer opportunities too as the quarter progresses, though the big gains were in Q2 last year and cannot mathematically be repeated this year. On emerging markets, while we do not expect volatility to the same degree as 2013, caution is warranted. The sell-side consensus has been surprisingly accurate on its call in 2021 for higher yields, wider breakevens and steeper curves; however, the call for a weaker dollar looks more suspect: emerging markets would see the most fallout if the dollar consensus slips on a summer tapering banana skin, so a ‘basket case basket’ may be in order on the short side.
免責聲明
本文由荷宝海外投资基金管理(上海)有限公司(“荷宝上海”)编制, 本文内容仅供参考, 并不构成荷宝上海对任何人的购买或出售任何产品的建议、专业意见、要约、招揽或邀请。本文不应被视为对购买或出售任何投资产品的推荐或采用任何投资策略的建议。本文中的任何内容不得被视为有关法律、税务或投资方面的咨询, 也不表示任何投资或策略适合您的个人情况, 或以其他方式构成对您个人的推荐。 本文中所包含的信息和/或分析系根据荷宝上海所认为的可信渠道而获得的信息准备而成。荷宝上海不就其准确性、正确性、实用性或完整性作出任何陈述, 也不对因使用本文中的信息和/或分析而造成的损失承担任何责任。荷宝上海或其他任何关联机构及其董事、高级管理人员、员工均不对任何人因其依据本文所含信息而造成的任何直接或间接的损失或损害或任何其他后果承担责任或义务。 本文包含一些有关于未来业务、目标、管理纪律或其他方面的前瞻性陈述与预测, 这些陈述含有假设、风险和不确定性, 且是建立在截止到本文编写之日已有的信息之上。基于此, 我们不能保证这些前瞻性情况都会发生, 实际情况可能会与本文中的陈述具有一定的差别。我们不能保证本文中的统计信息在任何特定条件下都是准确、适当和完整的, 亦不能保证这些统计信息以及据以得出这些信息的假设能够反映荷宝上海可能遇到的市场条件或未来表现。本文中的信息是基于当前的市场情况, 这很有可能因随后的市场事件或其他原因而发生变化, 本文内容可能因此未反映最新情况,荷宝上海不负责更新本文, 或对本文中不准确或遗漏之信息进行纠正。